knowledge -WSS

knowledge

author：explore 2025-09-30 00:45:52 - browse：15712

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Chimpanzees, like humans and whales, get menopause: Study

knowledge

WSS

Black vets could get higher VA benefits if race not used in lung test

Chemotherapy before breast cancer surgery might fuel metastasis

Physician subsidies by hospitals soar in wake of No Surprises Act

GSK’s asthma push continues as drug succeeds in Phase 3 trials

Is it ever OK for doctors to lie to their patients?

Chemotherapy before breast cancer surgery might fuel metastasis

explore

knowledge

entertainment

Apple is now the first public company to be valued at $3 trillion

Traditional Chinese medicine benefits explored in new JAMA study

Drug repurposing or repositioning? The language matters

Maker of FluMist seeks to allow at

Cancer drug shortages should be causing more outrage

Has Bernie Sanders reached the limit of his pharma bullying effort?

Hollywood unions extend contract negotiations for actors

Warren pushes Witty on UnitedHealth's control over physicians

Medical leaders decry Supreme Court decision on affirmative action

Brain MRIs reveal impact of 'toxic stress' on Black children

hotspot

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

Physician subsidies by hospitals soar in wake of No Surprises Act

Paying for Covid pills will soon shift to insurers

HHS's proposed rule does nothing to address the climate crisis

Medtronic CEO on promising devices for diabetes, hypertension

Novel spinal cord stimulator treats paralysis without surgery

knowledge

focus

focus

entertainment